Skip to main content

Table 2 Events and newly diagnosed co-morbidities during follow-up

From: Clinical course and outcomes of type-2 diabetic patients after treatment intensification for insufficient glycaemic control - results of the 2 year prospective DiaRegis follow-up

  Patients with a 2 year FU*
  Total patients (n) % of those with FU
Death 75/3058 2.5
Macrovascular complications 94/2979 3.2
  CAD 24/2979 0.8
  Stroke/TIA 42/2979 1.4
  PAD 37/2979 1.2
Microvascular complications 355/2979 11.9
  Any retinopathy 98/2979 3.3
  Any nephropathy 3/2979 0.1
  Any neuropathy 305/2979 10.2
  Amputation 9/2979 0.3
HF 128/2979 4.3
Non-fatal events combined 490/2979 18.5
All events 565/3058 18.5
  1. Legend: *Including those that died during follow-up; CAD, coronary artery disease; TIA, transitory ischaemic attack; PAD, peripheral artery disease; HF, heart failure; FU, follow-up.